Nanjing, China

Tian Zhu


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tian Zhu in Pharmaceutical Development

Introduction

Tian Zhu is a notable inventor based in Nanjing, China, recognized for his contributions to the field of pharmaceuticals. His work primarily focuses on the development of innovative compounds that have significant therapeutic potential. With a single patent to his name, he has made strides in the area of tyrosine kinase inhibitors.

Latest Patents

Tian Zhu's most recent patent involves the salt form of a tyrosine kinase inhibitor. The patent details acid addition salts of a specific compound, which includes various salts such as L-malate, hydrochloride, phosphate, and several others. This invention also encompasses a pharmaceutical composition that utilizes these salt compounds, along with a method of treatment that involves administering a therapeutically effective amount of the salt compounds as part of medicament preparations.

Career Highlights

Tian Zhu is currently employed at Jiangsu Simcere Pharmaceutical R&D Co., Ltd., where he continues to engage in research and development activities. His work at this esteemed company has allowed him to contribute to advancements in pharmaceutical science, particularly in the area of cancer treatment.

Collaborations

Tian Zhu collaborates with several esteemed colleagues, including Feng Tang and Qiu Jin. Their combined expertise enhances the research efforts at Jiangsu Simcere Pharmaceutical R&D Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Tian Zhu's contributions to the field of pharmaceuticals, particularly through his patent on tyrosine kinase inhibitors, highlight his role as an innovator in the industry. His ongoing work at Jiangsu Simcere Pharmaceutical R&D Co., Ltd. continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…